UK markets closed
NIKKEI 225
26,547.05 +119.40 (+0.45%) HANG SENG
19,950.21 +51.44 (+0.26%) CRUDE OIL
114.50 +4.01 (+3.63%) GOLD FUTURES
1,815.60 +7.40 (+0.41%) DOW
32,384.89 +188.23 (+0.58%) BTC-GBP
24,285.92 -255.65 (-1.04%)
Organon & Co. (OGN)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 02:17PM EDT. Market open.
| Previous close | 34.94 |
| Open | 34.74 |
| Bid | 35.52 x 800 |
| Ask | 35.56 x 800 |
| Day's range | 34.66 - 35.59 |
| 52-week range | 27.25 - 39.47 |
| Volume | |
| Avg. volume | 2,220,970 |
| Market cap | 8.979B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 6.67 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.12 (3.23%) |
| Ex-dividend date | 13 May 2022 |
| 1y target est | N/A |
- Business Wire
Organon Reports Results for the First Quarter Ended March 31, 2022
JERSEY CITY, N.J., May 05, 2022--Organon (NYSE: OGN) (the "company"), today announced its results for the first quarter ended March 31, 2022.
- Business Wire
Organon To Report First Quarter Results and Host Conference Call on May 5, 2022
JERSEY CITY, N.J., April 21, 2022--Organon To Report First Quarter Results and Host Conference Call on May 5, 2022
- Business Wire
Organon Enters into Global License Agreement to Commercialize Daré Bioscience’s XACIATO™ (clindamycin phosphate vaginal gel, 2%), FDA-Approved Treatment for Females 12 and Older with Bacterial Vaginosis (BV)
JERSEY CITY, N.J. & SAN DIEGO, March 31, 2022--Organon Enters into Global License Agreement to commercialize Daré Bioscience’s XACIATO™ (clindamycin phosphate vaginal gel, 2%)
© 2022 Yahoo. All rights reserved.
